chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had my last period about 3 days before my second shot. At the time, I was using Nuvaring for birth control, and had just put my Nuvaring in after my period when I got my second vaccine. Thirty days later, when I pulled the ring out to induce my period, I did not get my period. After waiting seven days, I then put my next Nuvaring in. I waited thirty days, and I again pulled the ring out to induce my period. I did not get my period. During my next cycle, I did not put my Nuvaring back in. I became pregnant. I then promptly miscarried. Since then, I have not had a normal cycle.
This case was reported by a consumer via sales rep and described the occurrence of pain in elbow in a 56-year-old male patient who received SHINGRIX for prophylaxis. In February 2019, the patient received the 2nd dose of SHINGRIX. In February 2019, less than a month after receiving SHINGRIX, the patient experienced pain in elbow and injection site reaction. In February 2019, the outcome of the pain in elbow was recovered/resolved. On an unknown date, the outcome of the injection site reaction was unknown. It was unknown if the reporter considered the pain in elbow and injection site reaction to be related to SHINGRIX. The patient received SHINGRIX vaccine in left arm, on the top near the shoulder. The patient stated that he might be experiencing a reaction to the SHINGRIX vaccine which was he received two weeks ago before from the date of reporting. The patient had minimal injection site reactions except for his left elbow. The patient was having extreme pain in his elbow when it was brushed up against something. The elbow was not swollen or sore to the touch and the acute pain was went away. It was unknown if the reporter agreed to follow up from GlaxoSmithKline.
Right arm was warm; Itchy; Red; Rash; Swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Right arm was warm), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE ERYTHEMA (Red), VACCINATION SITE RASH (Rash) and VACCINATION SITE SWELLING (Swollen) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037F21A) for COVID-19 vaccination.     The patient's past medical history included Lymph node excision (lymph node removed from her right arm 15 years ago) and Lymph node excision (also got her lymph node removed from her left arm part of her breast cancer) in June 2021. Concurrent medical conditions included Breast cancer.    On 09-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Sep-2021, the patient experienced VACCINATION SITE WARMTH (Right arm was warm), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE ERYTHEMA (Red), VACCINATION SITE RASH (Rash) and VACCINATION SITE SWELLING (Swollen). At the time of the report, VACCINATION SITE WARMTH (Right arm was warm) and VACCINATION SITE SWELLING (Swollen) outcome was unknown and VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE ERYTHEMA (Red) and VACCINATION SITE RASH (Rash) had not resolved.            No concomitant medications information was reported. Patient used ice to treat her symptoms  Patient use a soap, regularly as it was recommended by her doctor due to her breast cancer.  .
could not look at the sun/eyes in the sunlight hurt; This spontaneous case was reported by a patient and describes the occurrence of PHOTOPHOBIA (could not look at the sun/eyes in the sunlight hurt) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On 13-Jun-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jun-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PHOTOPHOBIA (could not look at the sun/eyes in the sunlight hurt). At the time of the report, PHOTOPHOBIA (could not look at the sun/eyes in the sunlight hurt) outcome was unknown.     No concomitant medications were reported.  The reporter stated that she received her fourth dose of the Moderna Covid-19 Vaccine on Monday. During Tuesday and Wednesday she reported she could not look at the sun. Her eyes in the sunlight hurt, even with sunglasses. She never had this type of reaction before. She stated she was going to see her eye doctor.  No treatment medications were reported.   Reporter did not allow further contact
Nausea, severe muscle pain and cramps, chills, joint pain,  severe headache, lasted 2days, chiropractor visit
Received 2nd dose more than 35 days after the first dose; Patient received half dose booster instead of the 2nd primary full dose; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose more than 35 days after the first dose) and ACCIDENTAL UNDERDOSE (Patient received half dose booster instead of the 2nd primary full dose) in a 20-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 056M21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 16-Jun-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 16-Jun-2022, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose more than 35 days after the first dose) and ACCIDENTAL UNDERDOSE (Patient received half dose booster instead of the 2nd primary full dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose more than 35 days after the first dose) and ACCIDENTAL UNDERDOSE (Patient received half dose booster instead of the 2nd primary full dose) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported. Nurse stated 2nd primary dose was given as a half dose by mistake. Nurse stated that, the patient received half dose booster by mistake, instead of the 2nd primary full dose. The 2nd dose was administered more than 35 days after the first Moderna COVID-19 primary full dose.
Headache  On Jan 1, 2021 10:00 had facial droop with headache, went to ED  Narrative:  went to ED Jan 1 after onset of facial droop with headache around 10:00am, diagnosed with Bell's Palsy, treated with Toradol, Acyclovir, Benadryl and 7 day course of Prednisone 60mg daily and acyclovir 1000mg q8 hours x 7  days
Patient developed asymptomatic COVID-19 infection approximately three days after first dose of vaccine. Detected on serial testing of nursing home staff.
Hyperpigmentation with central blistering developed over the course of the day -> pt was given topical spray anesthetic at time of vaccination - area consistent with area topical was sprayed.
arm was swollen; arm was a rashy red color; arm was itchy (like a bee sting); arm was a rashy red color; arm begun to hurt; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm begun to hurt), VACCINATION SITE SWELLING (arm was swollen), VACCINATION SITE RASH (arm was a rashy red color), VACCINATION SITE PRURITUS (arm was itchy (like a bee sting)) and VACCINATION SITE ERYTHEMA (arm was a rashy red color) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Oct-2021, the patient experienced VACCINATION SITE PAIN (arm begun to hurt). On 26-Oct-2021, the patient experienced VACCINATION SITE SWELLING (arm was swollen), VACCINATION SITE RASH (arm was a rashy red color), VACCINATION SITE PRURITUS (arm was itchy (like a bee sting)) and VACCINATION SITE ERYTHEMA (arm was a rashy red color). At the time of the report, VACCINATION SITE PAIN (arm begun to hurt), VACCINATION SITE SWELLING (arm was swollen), VACCINATION SITE RASH (arm was a rashy red color), VACCINATION SITE PRURITUS (arm was itchy (like a bee sting)) and VACCINATION SITE ERYTHEMA (arm was a rashy red color) outcome was unknown.            Concomitant medications was not provided by the reporter.  Treatment information was not provided.
Kidney pain, chills, extreme vomiting for several hours starting around 1:30 AM.
I awoke to find the lymph nodes in my (L) neck swollen. Same side as injection. As the day progressed the swelling involved the muscles of my neck. By 2:00 pm the (L) side of my face and tongue was going numb. By 3:00 the inside of my throat was narrowing. Effort to swallow.  Called Dr. office and was instructed to go to the ER.  CT scan revealed swollen lymph node in the clavicle and neck.  Also swollen muscles in (L) neck.  No signs of bacterial infection. Face and neck stayed swollen and facial numbness for 5 day.  Frontal headace on first day also with ringing in my L ear. Involuntary movement of (L)periorbital eye muscles. I was given Bactrim DS and Keflex po. Followed up with Dr. the next day. No TX. Ran low grade fever 7 days 99-101.
A non-serious spontaneous report of accidental exposure and lost her voice has been received from an immunization coordinator concerning an adult female subsequent to H1N1, Intranasal. The patient's past medical history and concomitant medications were not reported. The patient is a nurse who administered H1N1, Intranasal to patients starting 01-Oct-2009. The patient did not receive the vaccine. Within the past three weeks in October 2009, the patient has experienced a loss of her voice for three weeks. The outcome of the event was not reported.
Telephone call form doctor, client's PCP, who states client presented to his office with shingles presentation with patches from her upper arm to her hand.  It is only on right arm. Client complained of burning and itching on arm. Client denies fever or chills. PCP states will treat sxs. Spoke later with client who states arm still hurts but seems to be doing better. States PCP gave her oral medicine for hives to help relieve symptoms and to return to office on Monday.
RED SPLOTCHES (SIMILAR TO SUNBURN) WITH LITTLE TO NO ITCH OVER MAJORITY OF BODY
Shot taken on a tuesday 12:45 Pm.  starting around 6 mild pain to injection area, Mild nausea, fatigue, dizziness.  Disturbed sleep.  Joint pain overnight.  Took advil during the night and helped immensely.  Following day mild dizziness and fatigue, just feeling slightly unwell.    Slept 9 hours that night where normally sleep 6-7.   Thursday  morning back to 85% and by end of day back to normal.
slow onset rash beginning in injected arm in first 24 hours then progressing to other areas (neck, trunk) after 48 hours.  patient placed on cortisone therapy (methylprednisolone dosepak) on 8/16/19
Received Expired Booster; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Booster) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Booster). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received Expired Booster) outcome was unknown.            Concomitant information was not reported. Treatment information was not reported.
It was reported that a 5 1/2 year-old male vaccinated with DTaP and MMR on 9/12/02. Within 30-45 minutes after vaccination, patient developed generalized urticaria and swelling of the periorbital area and lips. Patient treated with Benadryl, Epinephrine, and Decadron. Patient's oxygen saturation was 98%. Patient recovered. Follow up on 01/21/04: "It was reported that: 'reviewed, no additional information at this time.' Case is closed."
Patient took oral typhoid over the course of 1 week as directed.  1 day after completion of the vaccine, patient had high fevers (103), rash and body aches.
Information has been received regarding a case in litigation, from a lawyer, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 07-NOV-2015, the patient was vaccinated with ZOSTAVAX, due to health care professional recommendation, for permanent prevention and protection against shingles and zoster-related injuries (prophylaxis) (strength, anatomical location, dose, route of administration, lot # and expiration date were not provided). On an unknown date, the patient experienced shingles (herpes zoster) and other zoster-related injuries despite being inoculated with the ZOSTAVAX vaccine (vaccination failure). On an unspecified date in 2018, the patient was treated by a health care provider for shingles. It was also reported that, on unknown dates, the patient suffered serious physical, emotional and economic damages as a result. In addition, the patient would continue to suffer ongoing injuries, included but not limited to: mental and physical pain and suffering (Emotional distress and pain), extensive medical care and treatment for these injuries, significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of pre-existing conditions and activations of laten conditions, lost wages, loss of earning capacity and other losses and damages. At the time of report, the patient was not recovered from emotional distress and pain, and the outcome of the patient regarding the vaccination failure, herpes zoster, quality of life decreased and the pre-existing unspecified conditions aggravated was unknown. The reporter considered the adverse events to be related to ZOSTAVAX. The reporter considered the events to be disabling, life-treathening and medically significant.
I got my period in the middle of the night. I am perimenopausal and haven't had a period in 12 months. Also, severe chills, body aches, headache.
This spontaneous case reported by a consumer, describes the occurrence of pruritus (itching chest and neck) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunisation. Co-suspect product included Tyvaso (treprostinil sodium) inhalation gas for secondary pulmonary arterial hypertension. Concurrent medical conditions included secondary pulmonary arterial hypertension. Concomitant products included Adempas (riociguat), Eliquis (apixaban) and Opsumit (macitentan) for an unknown indication. On Nov 11, 2019, patient started Tyvaso (treprostinil sodium), unknown route at an unspecified dose, four times per day. On an unknown date, patient received the third dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced pruritus (itching chest and neck). At the time of the report, pruritus (itching chest and neck) outcome: unknown. No treatment information provided.
SWEATING; ACHY; FATIGUE; BLISTER ON INSIDE OF LIP; AREA UNDER NOSTRIL ON RIGHT SIDE  IS SWOLLEN AND TENDER TO THE  TOUCH; SORENESS ON NECK; This spontaneous report received from a patient concerned a 64 year old of unspecified sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 0428218, expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 14:00 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced soreness on neck. On 07-APR-2021, the subject experienced blister on inside of lip. On 07-APR-2021, the subject experienced area under nostril on right side is swollen and tender to the touch. On 08-APR-2021, the subject experienced sweating. On 08-APR-2021, the subject experienced achy. On 08-APR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from blister on inside of lip, area under nostril on right side is swollen and tender to the touch, sweating, fatigue, and achy, and the outcome of soreness on neck was not reported. This report was non-serious.
From initial information received on 5/20/2005 from the patient regarding an adverse event occurring, it was reported that the 57 year old female received her first dose of Decavac, lot number U1211DA, administered in the left deltoid on 5/14/2005 at 12:00pm due to a cat scratch. Two days later, on 5/16/2005, the patient developed flu like symptoms, aching all over and welts (also reported as hives) on her back and chest, which enlarged to pancake size the following day. The patient was seen in the ER and was treated with Benadryl and Zyrtec. At the time of this report, the patient continues to have hives and has contacted a physician. She has not recovered from these events. Follow up received on 9/23/2005. No additional information received. Further information requested. Case upgrade to Serious 2/7/2006 (OMIC). Follow up information received on 2/7/2006 from the patient. The Decavac vaccination was the patients second dose of Tetanus. She received her first dose 10-12 years ago for a dog bite. Per the patient, she has had persistent large welts and facial swelling since 5/15/2005. She was seen by an allergist (date not reported) and was told that this was angioedema. She has been treated for this with Benadryl, Singulair, and Allegra. An MRI and CAT scan have been completed (date and results not reported). The patient has an extensive history of allergies to cats, latex, shellfish, eggs, acidic foods, dust, mold and penicillin. Per the patient, she had a cat bite at the time of vaccination. The patient has not recovered from these events at the time of this report.
Information has been received from a pharmacist concerning a male who on 12-Nov-2008 was vaccinated subcutaneously with a dose of ZOSTER (Oka/Merck) at the pharmacy.  On 13-NOV-2008 the patient developed facial swelling and tenderness of the left cheek.  On 13-NOV-2008 the patient consulted the pharmacist and was suggested to take BENADRYL.  No laboratory or diagnostics tests were performed.  At the time of this report, 13-NOV-2008. the events persisted.  Additional information has been requested. 03/27/09 This is in follow-up to report(s) previously submitted on 12/23/2008. Follow up information received from the pharmacist indicated that the 63 year old male patient received the first dose of ZOSTAVAX (Oka/Merck) (lot# 663196/1417X) SQ on 12-NOV-2008. On 13-NOV-2008, the patient developed left facial cheeck swollen for 3 days. On day 3, the patient developed rash at injection site. At the time of the report, on 08-JAN-2009, the result of the adverse events was unknown. Additional information has been requested.
he had a 'tingly' sensation; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An adult male patient received bnt162b2 (BNT162B2) (Lot number: EWO182) as dose 2, single and (Lot number: EWO175) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PARAESTHESIA (non-serious) with onset 10Jun2021, outcome "unknown", described as "he had a 'tingly' sensation". The event "he had a 'tingly' sensation" was evaluated at the physician office visit. It was unknown if therapeutic measures were taken as a result of paraesthesia.  Additional information: It was unknown if other vaccine taken in four weeks, covid prior to vaccination and covid tested post vaccination  Follow-up attempts are completed. No further information is expected.
pt recv vax & devel fever of 104, swelling of the arm into which pnu immune 23 was injected, h/a, vomiting, puffy eyes & blurred vision;
I was given the flu shot and the vaccine in the same day. I received one in each arm. The covid vaccine was Pfizer as listed above. I started feeling sick on the 18 of April.  Fatigue  headaches joint pain chest pain -doctors said it could e from coughing so much cough  unsure about the sore throat  I had the oh i am getting sick feeling. I took a at home test and it was negative. So I was scheduled to have a colonoscopy  done and I called to check to see what I needed to do anything before coming in. The night before I had to call and cancel because I felt so bad.. I called my Dr and she told me to wait a few days to retest. That Tuesday and Wednesday I felt horrible and sleep most of the day. I felt very dizzy and off balanced like I had vertigo. Thursday morning when I got up I took another at home COVID test and the results came in really fast this time and it was positive. I called my Dr again and she schedules me to come in and have an infusion that Friday. I went that Friday to the infusion center  and before the infusion I had a PCR Test were Positive the system had a H in there which stands for High Level.. My balance was still off so I had to use a wheelchair. I felt a little better but I could tell I was starting to recover. I had the worst brain fog  and it was so bad that I lost my phone while it was in my hand. I also found everything very funny. I spent a lot of time in bed until the 29 and that surprised me because I thought the infusion would make me feel better sooner. The first of May I could tell the recovery process had started but it was very slow. It took another 2 weeks before I started to feel normal. I was still having memory issues and I cant characterize it very well ....I lose words mid sentence and even full conversations just go blank. These things drive me up a wall. I also have issues putting things in the right order like I cant remember when I did something but I know I did it. The memory issues are slowly getting better but they are still here.
Noticed bug bite type rash on 5/18/18 on wrist, feet, ear, low grade fever that night, woke up on 5/19/18 and they were all blistered. Counted about 10 spots.
Pt woke up at 2 am next day and could not sleep.  Walked out to living room and started to see black for the next 2 minutes and became nauseous but than went away
Lethargy of severe nature, rash, fever, poor immunity to minor ailments, seizures, loss of speech. All vaccines make him ill: fever, loose bowels, vomiting, lethargy, apathy, seizures, neuro deficit, allergies to foods, weird viruses ie. herpangina-after varicella shot. All reactions were reported-many ER visits ensued. Hep B-caused chronic rash-not responsive to any meds. Worst reaction was at age 2- almost died-regression, seizures, aggression, insomnia, lost ability to speak, stopped walking. Diagnosis was autism and mental retardation. He was healthy and normal at birth-was a premie but only needed one week hospital stay following birth. The shots have caused neurological, immunological, digestive and developmental problems-he will never recover and there is no cure. The medical record received on 3/23/04 states autism, mental retardation, behavior problems, ADHD, sleep problems and self injury.